The finding of multiple uncommon ASD-related CNVs, each in a specific patient, further reflects the complexity and multifactorial nature of the ASD phenotype.
The nature of the differences at the nucleotide level between viral populations sampled at different times during antiviral treatment within each patient was further investigated at the amino acid level.
Within each population, each patient was further classified into three mutually exclusive cohorts: pre-MAW, post-MAW, and no-MAW.
Only the sample with the highest ZN smear grade for each patient was further processed and cultured.
A structured chart review was conducted for each patient, and further information was obtained from the involved infectious diseases specialist.
Additionally, in each patient, 3 6 further biopsies were obtained from up to two of the following colonic sites: cecum, ascending colon, transverse colon, or sigmoid colon.
Future studies should assess the mutation status of each patient to further identify those who are most likely to respond to this treatment strategy.
However, other important barriers (eg. Self-efficacy, family stress, adherence to dietary and exercise recommendations, travel distance to clinic) were unable to be recorded and included for each patient, preventing further evaluation of predictors of attendance and weight loss.
Increased interface with participants' PCPs above the standard chart notes could increase provider engagement and may have helped guide tailored intervention plans for each patient potentially further personalizing treatment.
The overarching suggestion is that rather than seeking to implement a screening tool in isolation, a procedure should instead be applied to yield an optimal indication of the need of each patient for further neurological examination.
